U.S. & Global Antimicrobial Resistance Laboratory Networks
CDC’s antimicrobial resistance laboratory networks support lab testing in health care, the community, and the environment (e.g., water, soil) in the United States and in collaboration with many countries abroad. Lab tests often help guide patient treatment, playing an important role in patient care and public health. Lab tests can also help detect emerging threats and prevent the spread of antimicrobial resistance—stopping outbreaks before they can start.
CDC coordinates and provides technical expertise to the national Antimicrobial Resistance Laboratory Network (AR Lab Network) and the Global Antimicrobial Resistance Laboratory & Response Network (Global AR Lab & Response Network).
These networks were established as part of CDC’s implementation of the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria, released in 2015 and 2020. These activities are funded through CDC antimicrobial resistance investments, collectively known as CDC’s Antimicrobial Resistance (AR) Solutions Initiative. Through these investments, CDC is transforming how the nation combats antimicrobial resistance.